Quantity performed	6
Exception?	No exception
Aufgrund der COVID-19-Pandemie unter anderem: - Eingeschränkte OP-Kapazitäten und Personalkapazitäten - Freihalten der Intensivbetten für mögliche COVID-Patienten - Allgemein Rückhaltung der Patienten bzgl. Krankenhausaufenthalten mit Verzicht auf invasive Diagnostik im Krankenhaus

Minimum quantities forecast

Complex operations on the pancreatic organ system

Overall result forecast presentation:	no
Quantity performed reporting year:	6
Quantity forecast year:	6
Examination by state associations?	no
Exemption?	no
Result of the examination by the federal state authorities?	no
Transitional arrangement?	no

Surgical treatment of breast cancer (mamma surgery)

Overall result forecast presentation:	yes
Quantity performed reporting year:	462
Quantity forecast year:	498
Examination by state associations?	yes
Exemption?	yes
Result of the examination by the federal state authorities?	yes
Transitional arrangement?	no

Implementation of resolutions of the Federal Joint Committee on quality assurance (G-BA)

No.	Explanation
CQ28	Guideline on quality assurance measures for liposuction procedures for stage III lipedema (QS-RL Liposuction)

Compliance with staffing requirements

Clarifying chat completed: no
Clarifying chat not completed: no
No participation in clarifying chat: no
Notification of non-fulfilment of nursing care not made: no

Further training
pursuant to Article 136b, para. 1, sentence 1, no. 1 of the SGB

Number	Group
106	Medical specialists (m/f) , psychological psychotherapists (m/f) and child and adolescent psychotherapists (m/f) who are subject to the obligation to undergo further training*
60	Number of medical specialists (m/f) from no. 1 who have completed a five-year period of further training and are therefore subject to the obligation to provide evidence
59	Number of those persons from no. 2 who have provided proof of further training according to Article 3 of the G-BA regulations

* according to the “Provisions of the Joint Federal Committee for the Further Training of Medical Specialists (m/f), Psychological Psychotherapists (m/f) and Child and Adolescent Psychotherapists (m/f) in Hospitals”

General information

Protection concept against (sexual) violence against children and young people

Advice on prevention and intervention in cases of violence and abuse

According to Section 4 (2) of the Quality Management Guideline, facilities must provide for the prevention of and intervention in cases of violence and abuse as part of their internal quality management. The aim is to prevent, recognise and respond appropriately to abuse and violence, particularly against vulnerable patient groups such as children and adolescents or people in need of help, and also to prevent it within the facility. The respective procedure is aligned with the size of the facility, the range of services and the patients in order to define customised solutions for sensitising the teams as well as other suitable preventative and interventional measures. These may include information materials, contact addresses, training/education, codes of conduct, recommendations for action/intervention plans or comprehensive protection concepts.

Is a protection concept in place? Yes
No care for children and young people

Ist aktuell in Erarbeitung und wird bis Quartal 1/2024 abgeschlossen.

Commentary on the protection concept

Gemäß § 4 Absatz 2 in Verbindung mit Teil B Abschnitt I § 1 der Qualitätsmanagement-Richtlinie haben sich Einrichtungen, die Kinder und Jugendliche versorgen, gezielt mit der Prävention von und Intervention bei (sexueller) Gewalt und Missbrauch bei Kindern und Jugendlichen zu befassen (Risiko- und Gefährdungsanalyse) und – der Größe und Organisationsform der Einrichtung entsprechend – konkrete Schritte und Maßnahmen abzuleiten (Schutzkonzept). In diesem Abschnitt geben Krankenhäuser, die Kinder und Jugendliche versorgen, an, ob sie gemäß § 4 Absatz 2 in Verbindung mit Teil B Abschnitt I § 1 der Qualitätsmanagement-Richtlinie ein Schutzkonzept gegen (sexuelle) Gewalt bei Kindern und Jugendlichen aufweisen.

Drug therapy safety

Steering committee

Drug commission

Training of employees on AMTS related topics

Use of standardised forms for drug medical history

Qualido - Intranet

31.10.2023

Electronic support for the admission and anamnesis process (e.g. import of patient master data or medication plans, use of a drug knowledge database, input screen for drugs or anamnesis information)

Process description for an optimal medication process (e.g. drug anamnesis – prescription – patient information – drug delivery – drug application – documentation – therapy monitoring – result evaluation)

Qualido - Intranet

31.10.2023

SOP on good prescription practices

AA_GF_0083

16.12.2019

Possibility of electronic prescription i.e. structured entry of active substances (or name of the preparation), form, dose, dose frequency (e.g. in the HIS, in prescription software)

Provision of one or more electronic drug information systems (e.g. Lauer-Taxe®, ifap klinikCenter®, Gelbe Liste®, Fachinfo-Service®)

Concepts for ensuring the error-free preparation of medications

Bereitstellung einer geeigneten Infrastruktur zur Sicherstellung einer fehlerfreien Zubereitung
Zubereitung durch pharmazeutisches Personal
Anwendung von gebrauchsfertigen Arzneimitteln bzw. Zubereitungen

Electronic documentation of the administration of drugs

Measures to minimise medication errors

Fallbesprechungen
Maßnahmen zur Vermeidung von Arzneimittelverwechslung
Teilnahme an einem einrichtungsübergreifenden Fehlermeldesystem (siehe Kapitel 12.2.3.2)

Measures to ensure seamless drug therapy after discharge

Aushändigung von arzneimittelbezogenen Informationen für die Weiterbehandlung und Anschlussversorgung der Patientin oder des Patienten im Rahmen eines (ggf. vorläufigen) Entlassbriefs
Aushändigung von Patienteninformationen zur Umsetzung von Therapieempfehlungen
Aushändigung des Medikationsplans
bei Bedarf Arzneimittel-Mitgabe oder Ausstellung von Entlassrezepten

Instruments and measures

The instruments and measures to promote drug therapy safety are presented with a focus on the typical procedures of the medication process in inpatient patient care. A special feature of the medication process in the inpatient environment is the transition management during admission and discharge. The instruments and measures listed below address structural elements, e.g. special IT equipment and work materials, as well as process aspects, such as work descriptions for particularly risky process steps or concepts for securing typical risk situations . In addition, proven measures to avoid or learn from medication errors can be specified. The hospital presents here which aspects it has already dealt with and which measures it has specifically implemented. The following aspects can be presented, if necessary using free text fields:
- Admission to hospital, including anamnesis
; Instruments and measures are presented for determining the old medication (drug history), the subsequent clinical assessment and the switch to the medication available in the hospital (house list), as well as for documenting both the patient's original medication and that for hospital treatment adapted medication.
- Medication process in the hospital
In this context, the following sub-processes are assumed as examples: drug history - prescription - patient information - drug delivery - drug use - documentation - therapy monitoring - result assessment. Instruments and measures for safe medication prescription can be presented, e.g. B. in terms of readability, clarity and completeness of the documentation, but also in terms of area of application, effectiveness, benefit-risk ratio, tolerability (including potential contraindications, interactions, etc.) and resource considerations. Information can also be provided to support reliable medication ordering, delivery and use or administration.
- Discharge
In particular, the measures taken by hospitals can be presented to ensure that information on drug therapy is structured and passed on to doctors and physicians providing further treatment, as well as the appropriate provision of patients with drug information, medication plans and medications. Drug prescriptions are made.

AMTS is the totality of measures to ensure an optimal medication process with the aim of reducing medication errors and thus avoidable risks for patients during drug therapy. A prerequisite for the successful implementation of these measures is that AMTS is practised as an integral part of daily routine in an interdisciplinary and multi-professional approach.

Special instrument-based equipment

Research & teaching

Job

FL09 - Doctoral supervision

Explanation

FL01 - Lectureships / teaching posts at colleges and universities

Explanation

FL08 - Editors of scientific journals/textbooks

Explanation

FL07 - Initiation and management of uni-centric/multi-centric clinical/scientific studies

Explanation

Dies erfolgt in den Kliniken für Chirurgie, Frauenheilkunde und Urologie, sowie in weiteren relevanten Bereichen.

FL04 - Project-related cooperation with colleges and universities

Explanation

Verschiedene Projekte mit Universität Regensburg, OTH Regenburg etc.

FL03 - Student training (clinical traineeship / internship year)

Explanation

FL05 - Participation in multi-centre Phase I/II studies

Explanation

FL06 - Participation in multi-centre phase III/IV studies

Explanation

FL02 - Lectureships / teaching posts at universities of applied sciences

Explanation

Training

Training in other healing professions

HB15 - Anaesthesia technical assistant (m/f)

Comment

HB07 - Surgical technical assistant (m/f)

Comment

HB05 - Medical technical radiology assistant (MTRA) (m/f)

Comment

HB17 - Auxiliary nurse (m/f)

Comment

HB19 - Nursing professionals

Comment

HB20 - Nursing professional B. Sc.

Comment

Hospital staff
Pharmaceutical personnel
- Number of pharmacists: 3
- Additional staff: 8
- Explanations: Apotheker/-innen: 2,82 VK weiteres Personal: 6,18 VK
- Nursing staff regulation

Service contact persons

Patient advocates

Herr Wolf Jaduczynski

Patientenfürsprecher

Landshuter Straße 65
93053 Regensburg

Phone: 0941 -782-2033
Mail: ed.jsc@rehcerpsreufnetneitap

Customer feedback management

Dipl. Pflegepädagin Sabine Bauer

Leitung Qualitäts-Prozess- und Risikomanagement

Landshuter Straße 65
93053 Regensburg

Phone: 0941 -782-2030
Mail: ed.jsc@reuabs

Bachelor of Arts (Soziale Arbeit) Barbara Königbauer

Mitarbeiterin

Landshuter Straße 65
93053 Regensburg

Phone: 0941 -782-2031
Mail: ed.jsc@reuabgineokb

Rechtsanwalt Erich Beer

Mitarbeiter

Landshuter Straße 65
93053 Regensburg

Phone: 0941 -782-2032
Mail: ed.jsc@reebe

Frau Tina Albrecht

Mitarbeiterin

Landshuter Straße 65
93053 Regensburg

Phone: 0941 -782-2034
Mail: ed.jsc@thcerblat

Quality management

Dipl. Pflegepädagogin (FH) Sabine Bauer

Leitung Qualitäts-, Prozess- und Risikomanagement

Landshuter Straße 65
93053 Regensburg

Phone: 0941 -782-2030
Mail: ed.jsc@reuabs

Hygiene officer

Prof. Dr. med. Alois Fürst

Direktor der Klinik für Chirurgie

Landshuter Straße 65
93053 Regensburg

Phone: 0941 -782-3310
Mail: ed.jsc@eigrurihc

PD Dr. med. Sylvia Pemmerl

medizinisch ärztliche Direktorin, curr. Krankenhaushygienikerin, Pandemiebeauftragte, Vorsitzende der Hygienekommission

Landshuter Straße 65
93053 Regensburg

Phone: 0941 -782-2004
Mail: ed.jsc@gnurheufstfeahcseg

Responsible for drug therapy

PD Dr. Michael Pawlik

Klinikdirektor Klinik für Anästhesiologie, Intensiv-, Palliativ- und Notfallmedizin

Landshuter Straße 65
93053 Regensburg

Phone: 0941 -782-3610
Mail: ed.jsc@eigoloisehtseana

Accessibility Officer

PD Dr. Stefan Seitz

Oberarzt

Landshuter Straße 65
93053 Regensburg

Phone: 0941 -782-3401
Mail: ed.jsc@eigolokeanyg

Company

General contact details of the hospital

Landshuter Straße 65
93053 Regensburg

Phone: 0941-782-0
Fax: 0941-782-2005
Mail: ed.jsc@gnurheufstfeahcseg

Nursing service management

Dipl. Pflegewirtin (FH) Eva-Maria Andraschko

Direktorin für Pflege- und Patientenmanagement

Landshuter Straße 65
93053 Regensburg

Phone: 0941 -782-2610
Mail: ed.jsc@noitkeridegelfp

B.A. Gesundheits- und Sozialmanagement Alexandra Stich

Direktorin für Pflege- und Patientenmanagement

Landshuter Straße 65
93053 Regensburg

Phone: 0941 -782-2610
Mail: ed.jsc@noitkeridegelfp

Head of administration

Dr. med. Thomas Koch

Geschäftsführer

Landshuter Straße 65
93053 Regensburg

Phone: 0941 -782-2010
Mail: ed.jsc@gnurheufstfeahcseg

PD Dr. med. Sylvia Pemmerl

Geschäftsleitung

Landshuter Straße 65
93053 Regensburg

Phone: 0941 -782-2004
Mail: ed.jsc@gnurheufstfeahcseg

Responsible for the quality report in the hospital management

Dr. med. Thomas Koch

Geschäftsführer

Landshuter Straße 65
93053 Regensburg

Phone: 0941 -782-2010
Mail: ed.jsc@hcokt

PD Dr. med. Sylvia Pemmerl

Med. Ärztl. Direktorin

Landshuter Straße 65
93053 Regensburg

Phone: 0941 -782-2004
Mail: ed.jsc@gnurheufstfeahcseg

Medical management

Prof. Dr. med. Olaf Ortmann

Ärztlicher Direktor

Landshuter Straße 65
93053 Regensburg

Phone: 0941 -782-3410
Mail: ed.jsc@eigolokeanyg

PD Dr. med. Sylvia Pemmerl

Med. Ärztl. Direktorin

Landshuter Straße 65
93053 Regensburg

Phone: 0941 -782-2010
Mail: ed.jsc@lremmeps

Regional care obligation for psychiatry?

IK number

IK: 260930061

Location number

Location number: 771144000

Old location number: 771144000

Hospital portrait for download